Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer
Top Ten Searches
post partum incontinence fibroid hpv colpotomy ovarian cyst curettage endometriosis intrauterine umbilical cordYour Article Summary
The role of serum CA-125 levels in early-stage epithelial ovarian cancer on preoperative CT and MRI
European Journal of Surgical Oncology, 06/30/09
Kim HS et al. – Study reports that serum CA-125 levels may be very useful for the prediction of advanced-stage disease in early-stage epithelial ovarian cancer (EOC) on preoperative CT and MRI
Methods- Aim was to identify the role of serum CA-125 levels in early-stage EOC on preoperative CT and MRI
- Clinical data of 101 pts were collected between Jan 2000-Dec 2007
- Clinical stage I (n=59) was defined as tumor limited to the ovaries with or w/o ascites
- Clinical stage II (n=42) was defined as tumor within the pelvis with or w/o ascites
- Primary endpoint: investigate the efficacy of serum CA-125 levels for the prediction of advanced-stage disease
- Secondary endpoints:
- To evaluate the accuracy of preoperative CT and MRI, and
- To examine the role of serum CA-125 levels as a prognostic factor for survival
- Results of preoperative CT and MRI were concordant with no peritoneal implants outside the pelvis in 50% and no lymph node metastasis in 70% pts
- Best cut-off values of serum CA-125 levels were 320 U/ml and 510 U/ml for the prediction of peritoneal implants outside the pelvis and lymph node metastasis
- Serum CA-125 level (≥320 U/ml) was a significant factor for the prediction of advanced-stage disease
- However, it was not an independent prognostic factor for survival
Today in Gynecologic Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Adjuvant radiotherapy and chemoradiation after surgery for cervical cancer
Cochrane Reviews, 10/09/09
Cost-Effectiveness of Human Papillomavirus Vaccination and Cervical Cancer Screening in Women Older Than 30 Years in the United States
Annals of Internal Medicine, 10/20/09
Ovarian cancer screening and early detection
Women's Health, 11/03/09
Today in Radiology/Diagnostics...keeping you current
Receive free subspecialty "5-minute updates" via email
Ultrasound is a useful adjunct to mammography in the assessment of breast tumours in all patients
International Journal of Clinical Practice, 10/12/09
One More Hurdle to Increasing Mammography Screening: Pubescent, Adolescent, and Prior Mammography Screening Experiences
Women's Health Issues, 11/04/09
Breast Cancer: Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09
Sponsor
Article Search
Sponsor


See Latest Articles


